Procurement OverviewVendor ManagementFee StructureRFP & ProcurementPilot StrategyImplementation RoadmapSuccess MetricsRisk & MitigationEnterprise Expansion
Procurement OverviewVendor ManagementFee StructureRFP & ProcurementPilot StrategyImplementation RoadmapSuccess MetricsRisk & MitigationEnterprise Expansion
Benefits & Procurement · Vendor & Contract Management
Benefits & Procurement Overview
What are we buying, from whom, at what cost, and on what terms? Vendor management, contract structure, and procurement process for the PayRX program.
Sample dataObserved
Total annual program spend
$39.07M
4 vendors
ObservedActive vendors
4
all contracts current
ObservedSLA compliance
4/4
vendors meeting targets
MeasuredFee at risk
$2.70M
25% of total fee
ObservedVendor portfolio
DetailsPayRX Pharmacy Network
GLP-1 Medication Supply
$29.16M
per member / month
PayRX Clinical Platform
Clinical Care Platform
$7.15M
per member / month
PayRX Care Team
Care Navigation & Coaching
$2.40M
per member / month
PayRX Analytics & Reporting
Data & Analytics
$360K
annual platform fee
Fee structure & at-risk terms
DetailsTotal per member / year
$5,400
GLP-1 medication$5,400100%
Clinical platform & providers$3,60066.7%
Care navigation & coaching$60011.1%
Guaranteed portion$8,100,000
At-risk (outcome-based)$2,700,000
Fee comparison across scenarios
Modeled| Metric | Conservative | Base | Optimistic |
|---|---|---|---|
| Enrolled members | NaN | NaN | NaN |
| Total annual fee | $8.10M | $10.80M | $16.20M |
| Fee at risk (25%) | $2.02M | $2.70M | $4.05M |
| Net economic impact | $3.02M | $4.02M | $6.03M |
Benefits plan design
GLP-1 Weight Management1000/30000 (20%)
Therapy: Semaglutide / TirzepatideCost: $450/moTarget: BMI ≥30 or BMI ≥27 with comorbidity
Cardiometabolic480/3200 (15%)
Therapy: Lifestyle + medicationCost: $180/moTarget: BP ≥140/90 or LDL ≥160
Diabetes Management360/1800 (20%)
Therapy: Metformin + lifestyleCost: $220/moTarget: HbA1c ≥6.5%
Hypertension300/2400 (12.5%)
Therapy: Lifestyle + medicationCost: $150/moTarget: BP ≥130/80
Contract renewal timeline
PayRX Care Team
Renewal evaluation due Q1 2027
Ends 2027-12-31
14 months left
PayRX Pharmacy Network
Active — no action needed
Ends 2028-12-31
26 months left
PayRX Clinical Platform
Active — no action needed
Ends 2028-12-31
26 months left
PayRX Analytics & Reporting
Active — no action needed
Ends 2028-12-31
26 months left
Employee Privacy Protected by Design
Employer reporting is designed to present aggregate workforce and health-program insights without exposing individual clinical records. Small-group reporting restrictions help reduce the risk of employee identification.
Sample dataPrivacy-restricted reporting
Aggregated information is not described as HIPAA-de-identified unless applicable de-identification requirements have been satisfied and verified.